Santen Pharmaceutical is a Japanese global healthcare company specializing in the development, manufacture, and distribution of prescription-based ophthalmic products. Founded in 1890, the company focuses on treating diseases of the eye with a strong commitment to innovation in the field of eye care. The company operates worldwide, with a strong presence in Asia, Europe, and North America.
Santen provides a wide range of pharmaceutical products, including treatments for glaucoma, dry eye disease, and other eye-related conditions. It focuses on innovative therapies and surgical solutions for ophthalmic care, offering prescription medications and surgical devices.
Santen is committed to sustainability through environmental management initiatives, such as reducing waste and improving resource efficiency. The company also focuses on ethical practices, ensuring that its products contribute to global eye health while minimizing environmental impact. It also emphasizes corporate social responsibility by improving access to eye care in underserved regions.
Santen operates in over 20 countries and regions, including Japan, Europe, North America, and Asia, with an expanding presence in emerging markets. The company's global operations are supported by research and manufacturing facilities located in key strategic locations worldwide.
Further Details
Some additional details about the company are listed below:
| Parameter | Details |
|---|---|
| Santen Pharmaceutical | https://www.santen.com/ |
| Company Name | Santen Pharmaceutical |
| Application Areas | Medical treatments for eye diseases, patient care, research & development |
| Sustainability Recognition | Focus on environmental sustainability, improving patient access |
| Key Technologies | Ophthalmic drug formulation, sustained release technology, eye health research |
| Industry | Pharmaceutical |
| Core Focus | Eye care products and services |
| Solutions Offered | Ophthalmic products, eye care solutions, drug delivery technologies |